These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18688768)

  • 1. [1,3-Beta-D-glucan measurement and its usefulness in the diagnosis of invasive fungal infections].
    Kocmanová I; Rácil Z; Koukalová D; Mayer J
    Klin Mikrobiol Infekc Lek; 2008 Jun; 14(3):88-92. PubMed ID: 18688768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serodiagnosis for deep-seated mycoses].
    Maesaki S
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(4):233-7. PubMed ID: 12402024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serologic diagnosis of fungal infections].
    Fujita S
    Nihon Rinsho; 2008 Dec; 66(12):2313-8. PubMed ID: 19069098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3-beta-D-glucan in immunocompromised patient suspected fungal infection.
    Susianti H; Parmadi L; Firani NK; Setyawan UA; Sartono TR
    J Clin Lab Anal; 2021 Jun; 35(6):e23806. PubMed ID: 33945177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances and limitations in the early diagnosis of invasive yeast infections].
    Pontón J; del Palacio A
    Rev Iberoam Micol; 2007 Sep; 24(3):181-6. PubMed ID: 17874854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-D-glucan, D-arabinitol].
    Mori T; Yamamoto Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():251-4. PubMed ID: 20942051
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparable Serum and Plasma 1,3-β-d-Glucan Values Obtained Using the Wako β-Glucan Test in Patients with Probable or Proven Fungal Diseases.
    De Carolis E; Marchionni F; Torelli R; Posteraro P; De Pascale G; Carelli S; Sanguinetti M; Posteraro B
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842228
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serological diagnosis for invasive fungal infections].
    Yoshida M
    Med Mycol J; 2013; 54(2):111-5. PubMed ID: 23760074
    [No Abstract]   [Full Text] [Related]  

  • 11. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
    Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
    Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.
    Obayashi T; Negishi K; Suzuki T; Funata N
    Clin Infect Dis; 2008 Jun; 46(12):1864-70. PubMed ID: 18462174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-glucan in the diagnosis of invasive fungal disease.
    Pasqualotto AC; Sukiennik TC
    Clin Infect Dis; 2008 Jul; 47(2):292-3; author reply 293-4. PubMed ID: 18564936
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of fungal infection: new technologies for the mycology laboratory.
    Alexander BD
    Transpl Infect Dis; 2002; 4 Suppl 3():32-7. PubMed ID: 12486790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple serum antigenic assays for diagnosis of invasive fungal infections in non-neutropenic adult patients].
    Jin J; Sun TY; Hu YJ; Li YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):660-4. PubMed ID: 21092632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (1 --> 3)-beta-D-glucan--a new marker for the early serodiagnosis of deep-seated fungal infections in humans.
    Kedzierska A
    Pol J Microbiol; 2007; 56(1):3-9. PubMed ID: 17419183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes.
    Obayashi T; Yoshida M; Mori T; Goto H; Yasuoka A; Iwasaki H; Teshima H; Kohno S; Horiuchi A; Ito A
    Lancet; 1995 Jan; 345(8941):17-20. PubMed ID: 7799700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.
    Presterl E; Parschalk B; Bauer E; Lassnigg A; Hajdu S; Graninger W
    Int J Infect Dis; 2009 Nov; 13(6):707-12. PubMed ID: 19157947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive mycoses: diagnostic challenges.
    Ostrosky-Zeichner L
    Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems and recent advances in measurement of (1-->3)-beta-D-glucan].
    Yoshida K; Shoji H; Niki Y
    Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):75-80. PubMed ID: 18451587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.